When trading pharmaceutical products between EFTA member states and Canada, manufacturers must provide proof of origin to demonstrate that production occurred in one of the partner countries.
Source: https://www.efta.int/
Tools that match this term
You might also be interested in these terms
Weekly: Top news, industry facts and insights from the world of logistics – free.
Content reviewed and editorially cleared.
Share your knowledge, ask follow-up questions, or add practical insights to this page. Every contribution is moderated before publication.